Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women

Bone

Volumn 40, Issue 4, 2007, Pages 997-1005

  Ezura, Yoichi ^a   Nakajima, Toshiaki ^a   Urano, Tomohiko ^b   Sudo, Yoshihiro ^a   Kajita, Mitsuko ^a   Yoshida, Hideyo ^c   Suzuki, Takao ^c   Hosoi, Takayuki ^d   Inoue, Satoshi ^b   Shiraki, Masataka ^e   Emi, Mitsuru ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^d Tokyo Metropolitan Institute of Gerontology   (Japan)

^e RESEARCH INSTITUTE AND PRACTICE FOR INVOLUTIONAL DISEASES   (Japan)

Author keywords

Association study; Bone mineral density; Low density lipoprotein receptor related protein; LRP5; Quantitative trait; Single nucleotide polymorphism

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; WNT PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; JAPAN; LRP5 GENE; MULTIPLE REGRESSION; NORMAL HUMAN; OSTEOPOROSIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; VERTEBRA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BONE DENSITY; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; JAPAN; LDL-RECEPTOR RELATED PROTEINS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; VARIATION (GENETICS);

EID: 33847720301     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.06.025     Document Type: Article

References (43)

1. Riggs B.L., and Melton III L.J. Involutional osteoporosis. N. Engl. J. Med. 314 (1986) 1676-1686
2. Hartmann C., and Tabin D.J. Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 140 (2001) 341-351
3. Yang Y., Topol L., Lee H., and Wu J. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 130 (2003) 1003-1015
4. Kato M., Patel M.S., Levasseur R., Lobov I., Chang B.H.J., Glass II D.A., et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157 (2002) 303-314
5. Mao J., Wang J., Liu B., Pan W., Farr III G.H., Flynn C., et al. Low-density lipoprotein receptor-related protein-5 binds to axin and regulates the canonical Wnt signaling pathway. Mol. Cell 7 (2001) 801-809
6. Zorn A.M. Wnt signaling: antagonistic Dickkopfs. Curr. Biol. 11 (2001) R592-R595
7. Gong Y., Vikkula M., Boon L., Liu J., Beighton P., Ramesar R., et al. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am. J. Hum. Genet. 59 (1996) 146-151
8. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107 (2001) 513-523
9. Little R.D., Carulli J.P., Del Mastro R.G., Dupuis J., Osborne M., Folz C., et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 70 (2002) 11-19
10. Boyden L.M., Mao J., Belsky J., Mitzner L., Farhi A., Mitnick M.A., et al. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346 (2002) 1513-1521
11. Van Wesenbeeck L., Cleiren E., Gram J., Beals R.K., Benichou O., Scopelliti D., et al. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am. J. Hum. Genet. 72 (2003) 763-771
12. Grant S.FA., Reid D.M., Blake G., Herd R., Fogelman I., and Ralston S.H. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 gene. Nat. Genet. 14 (1996) 203-205
13. Tavtigian S.V., Simard J., Teng D.H., Abtin V., Baumgard M., Beck A., et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat. Genet. 27 (2001) 172-224
14. Rebbeck T.R., Walker A.H., Zeigler-Johnson C., Weisburg S., Martin A.M., Nathanson K.L., et al. Association of HPC2/ELAC2 genotypes and prostate cancer. Am. J. Hum. Genet. 67 (2000) 1014-1019
15. Urano T., Shiraki M., Ezura Y., Fujita M., Sekine E., Hoshino S., et al. Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density. J. Bone Miner. Metab. 22 (2004) 341-345
16. Mizuguchi T., Furuta I., Watanabe Y., Tsukamoto K., Tomita H., Tsujihata M., et al. LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density. J. Hum. Genet. 49 (2004) 80-86
17. Koh J.M., Jung M.H., Hong J.S., Park H.J., Chang J.S., Shin H.D., et al. Association between bone mineral density and LDL receptor-related protein 5 gene polymorphisms in young Korean men. J. Korean Med. Sci. 19 (2004) 407-412
18. Ferrari S.L., Deutsh S., Choudhury U., Chevalley T., Bonjour J.P., Dermitzakis E.T., et al. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am. J. Hum. Genet. 74 (2004) 866-875
19. Orimo H., Hayashi Y., Fukunaga M., Sone T., Fujiwara M., Shiraki M., et al. Diagnostic criteria for primary osteoporosis: year 2000 revision. J. Bone Miner. Metab. 19 (2001) 331-337
20. Ezura Y., Nakajima T., Kajita M., Ishida R., Inoue S., Yoshida H., et al. Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density. J. Bone Miner. Res. 18 (2003) 1642-1649
21. Iwasaki H., Emi M., Ezura Y., Ishida R., Kajita M., Kodaira M., et al. Association of a Trp16Ser variation in the gonadotropin releasing hormone (GnRH) signal peptide with bone mineral density, revealed by SNP-dependent PCR (Sd-PCR) typing. Bone 32 (2002) 185-190
22. Ogawa S., Hosoi T., Shiraki M., Orimo H., Emi M., Muramatsu M., et al. Association of estrogen receptor b gene polymorphism with bone mineral density. Biochem. Biophys. Res. Commun. 269 (2000) 537-541
23. Okubo M., Horinishi A., Kim D.H., Yamamoto T.T., and Murase T. Seven novel sequence variations in the human low density lipoprotein receptor related protein 5 (LRP5) gene. Hum. Mutat. 19 (2002) 186
24. Mein C.A., Barratt B.J., Dunn M.G., Siegmund T., Smith A.N., Esposito L., et al. Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation. Genome Res. 10 (2000) 330-343
25. Haga H., Yamada R., Ohnishi Y., Nakamura Y., and Tanaka T. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190 562 genetic variations in the human genome. J. Hum. Genet. 47 (2002) 605-610
26. Miller P.T., Sardina I.B., Saccone N.L., Putzel J., Laitinen T., Cao A., et al. Juxtaposed regions of extensive minimal linkage disequilibrium in human Xq25 and Xq28. Nat. Genet. 25 (2000) 324-328
27. Thompson E.A., Deeb S., Walker D., and Motulsky A.G. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am. J. Hum. Genet. 42 (1988) 113-124
28. Ng P.C., and Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res. 12 (2002) 436-446
29. Koay M.A., Woon P.Y., Zhang Y., Miles L.J., Duncan E.L., Ralston S.H., et al. Influence of LRP5 polymorphisms on normal variation in BMD. J. Bone Miner. Res. 19 (2004) 1619-1627
30. Koller D.L., Ichikawa S., Johnson M.L., Lai D., Xuei X., Edenberg H.J., et al. Contribution of the LRP5 gene to normal variation in peak BMD in women. J. Bone Miner. Res. 20 (2005) 75-80
31. Babij P., Zhao W., Small C., Kharode Y., Yaworsky P.J., Bouxsein M.L., et al. High bone mass in mice expressing a mutant LRP5 gene. J. Bone Miner. Res. 18 (2003) 960-974
32. Eisman J.A. Genetics of osteoporosis. Endocr. Rev. 20 (1999) 788-804
33. Peacock M., Turner C.H., Econs M.J., and Foroud T. Genetics of osteoporosis. Endocr. Rev. 23 (2002) 303-326
34. Hobson E.E., and Ralston S.H. Role of genetic factors in the pathophysiology and management of osteoporosis. Clin. Endocrinol. 54 (2001) 1-9
35. Koller D.L., Econs M.J., Morin P.A., Christian J.C., Hui S.L., Parry P., et al. Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis. J. Clin. Endocrinol. Metab. 85 (2000) 3116-3120
36. Reid I.R. Relationships among body mass, its components, and bone. Bone 31 (2002) 547-555
37. Amling M., Takeda S., and Karsenty G. A neuro(endo)crine regulation of bone remodeling. BioEssays 22 (2000) 970-975
38. Whipple T., Sharkey N., Demers L., and Williams N. Leptin and the skeleton. Clin. Endocrinol. 57 (2002) 701-711
39. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111 (2002) 305-3017
40. Shiraki M., Shiraki Y., Aoki C., Hosoi T., Inoue S., Kaneki M., et al. Association of bone mineral density with apolipoprotein E phenotype. J. Bone Miner. Res. 12 (1997) 1438-1445
41. Lecka-Czernik B., Moerman E.J., Grant D.F., Lehmann J.M., Manolagas S.C., and Jilka R.L. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 143 (2002) 2376-2384
42. McFarlane S.I., Muniyappa R., Francisco R., and Sowers J.R. Pleiotropic effects of statins: lipid reduction and beyond. J. Clin. Endocr. Metab. 87 (2002) 1451-1458
43. Johnson M.L., Harnish K., Nusse R., and Van Hul W. LRP5 and Wnt signaling: a union made for bone. J. Bone Miner. Res. 19 (2005) 1749-1757